In asthma, the treatment of DNA‐PKcs inhibitor NU7441 blocks CD3 and CD28, induces T‐bet and Gata3 expression in CD4+ T cells, and stops Th1 and Th2 cells differentiation (Figure 5A).166. This evidence concerns the gene PRKDC and asthma.